Potential antileukemic and immunosuppressive drugs. 3. Effects of homocyclic ring substitution on the in vitro drug activity of 4-nitrobenzo-2,1,3-oxadiazoles (4-nitrobenzofurazans) and their N-oxides (4-nitrobenzofuroxans).
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D005033:Ethylmaleimide / Q000037:antagonists & inhibitors; D007166:Immunosuppressive Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D009581:Nitrofurans / Q000138:chemical synthesis / Q000494:pharmacology*; D009696:Nucleic Acids / Q000096:biosynthesis; D010069:Oxadiazoles / Q000138:chemical synthesis / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D011817:Rabbits; D013057:Spectrum Analysis; D013329:Structure-Activity Relationship; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014466:Ultraviolet Rays; D014529:Uridine / Q000378:metabolism
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009581:Nitrofurans; D009696:Nucleic Acids; D010069:Oxadiazoles; D013438:Sulfhydryl Compounds; D005033:Ethylmaleimide; D013936:Thymidine; D014529:Uridine